Paediatric Hidradenitis Suppurativa: Successful Treatment With Bimekizumab and Multidimensional Impact on Quality of Life
Abstract
This case report describes the successful treatment of a 15-year-old male with severe hidradenitis suppurativa (HS) using bimekizumab. The patient, previously unresponsive to adalimumab, showed significant clinical and psychological improvement after 6 months of treatment, highlighting the potential of bimekizumab as a therapeutic option for paediatric HS.
Fields of Study & Subjects
Hidradenitis Suppurativa and Treatments
Autoimmune and Inflammatory Disorders
Osteomyelitis and Bone Disorders Research
Publication details
- Journal / source
- Australasian Journal of Dermatology
- Volume
- 67
- Issue
- 3
- Pages
- 166–168
- Publication date
- 14 January 2026
- Language
- EN